1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Chung, D.A. Zuiderweg, E.R. Neubig, R.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 41 3596 3604 10.1021/bi015811+ 11888275 NMR structure of the second intracellular loop of the alpha 2A adrenergic receptor: evidence for a novel cytoplasmic helix. 2002 10.2210/pdb1ho9/pdb pdb_00001ho9 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 3796.449 ALPHA-2A ADRENERGIC RECEPTOR SECOND INTRACELLULAR LOOP (RESIDUES 118-149) D130I 1 syn polymer ALPHA-2A ADRENOCEPTOR no no TSSIVHLCAISLIRYWSITQAIEYNLKRTPRR TSSIVHLCAISLIRYWSITQAIEYNLKRTPRR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-07-24 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details Mean structure of Wild-type T3-I2 peptide Best 20 DYANA conformers of wild-type T3-I2 peptide Mean structure of D130I mutant T3-I2 peptide RCSB Y RCSB 2000-12-10 REL REL THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE OF THE PEPTIDE OCCURS NATURALLY IN HOMO SAPIENS (HUMAN). sample target function 100 20 2D NOESY 2D TOCSY 2D COSY 50 mM NACL 4.50 303.00 K 50 mM 4.50 303.00 K SIMULATED ANNEALING IN TORSION ANGLE SPACE 0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 90% H2O/10% D2O 0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 100% D20 Guntert structure solution DYANA Bartels data analysis XEASY Delaglio processing NMRPipe Johnson data analysis NMRView Glaser data analysis SPSCAN Guntert refinement DYANA 800 Varian INOVA THR 1 n 1 THR 1 A SER 2 n 2 SER 2 A SER 3 n 3 SER 3 A ILE 4 n 4 ILE 4 A VAL 5 n 5 VAL 5 A HIS 6 n 6 HIS 6 A LEU 7 n 7 LEU 7 A CYS 8 n 8 CYS 8 A ALA 9 n 9 ALA 9 A ILE 10 n 10 ILE 10 A SER 11 n 11 SER 11 A LEU 12 n 12 LEU 12 A ILE 13 n 13 ILE 13 A ARG 14 n 14 ARG 14 A TYR 15 n 15 TYR 15 A TRP 16 n 16 TRP 16 A SER 17 n 17 SER 17 A ILE 18 n 18 ILE 18 A THR 19 n 19 THR 19 A GLN 20 n 20 GLN 20 A ALA 21 n 21 ALA 21 A ILE 22 n 22 ILE 22 A GLU 23 n 23 GLU 23 A TYR 24 n 24 TYR 24 A ASN 25 n 25 ASN 25 A LEU 26 n 26 LEU 26 A LYS 27 n 27 LYS 27 A ARG 28 n 28 ARG 28 A THR 29 n 29 THR 29 A PRO 30 n 30 PRO 30 A ARG 31 n 31 ARG 31 A ARG 32 n 32 ARG 32 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A O H ILE TRP 13 16 1.56 4 A A O H ILE ARG 10 14 1.56 8 A A O H VAL ALA 5 9 1.58 9 A A O H VAL ALA 5 9 1.60 10 A A O H CYS LEU 8 12 1.51 10 A A O H LEU SER 7 11 1.59 11 A A O H CYS LEU 8 12 1.54 11 A A O H LEU SER 7 11 1.58 12 A A O H LEU SER 7 11 1.53 12 A A O H ILE ALA 18 21 1.57 13 A A O H LEU SER 7 11 1.52 16 A A O H ALA ILE 9 13 1.59 18 A A O H ILE ALA 18 21 1.52 18 A A O H ILE CYS 4 8 1.53 1 A SER 17 -67.99 67.58 1 A ILE 18 -160.39 -44.88 1 A ALA 21 -108.82 69.23 1 A ARG 28 -43.95 166.33 1 A THR 29 62.03 66.19 1 A ARG 31 61.10 142.32 2 A CYS 8 -145.98 -63.59 2 A SER 11 -91.17 44.97 2 A SER 17 -67.07 70.23 2 A ILE 18 -164.53 -43.82 2 A ILE 22 -151.30 -70.95 2 A THR 29 62.70 69.66 2 A ARG 31 51.72 101.04 3 A CYS 8 -152.13 -65.73 3 A SER 11 -91.15 37.10 3 A ILE 13 -138.90 -50.83 3 A TYR 15 -95.02 32.30 3 A ILE 18 -144.20 -47.37 3 A ALA 21 -103.52 66.39 3 A LEU 26 -44.43 -70.77 3 A THR 29 -157.78 87.36 3 A ARG 31 -178.08 136.12 4 A SER 17 -69.00 63.77 4 A ILE 18 -155.43 -46.01 4 A ALA 21 -116.48 56.31 4 A ILE 22 -147.08 -62.11 4 A LEU 26 -91.66 53.88 4 A LYS 27 -177.20 64.92 4 A ARG 31 -179.97 96.75 5 A SER 17 -62.79 79.33 5 A ILE 18 -176.75 -39.43 5 A ALA 21 -115.80 68.25 5 A LYS 27 -174.43 67.08 5 A THR 29 52.13 81.04 6 A CYS 8 -154.99 -63.39 6 A SER 11 -104.67 44.55 6 A ILE 13 -54.51 -74.22 6 A ARG 14 -38.83 -29.91 6 A TYR 15 -90.78 43.68 6 A ILE 18 -145.36 -47.34 6 A ALA 21 -112.22 67.18 6 A ILE 22 -131.15 -59.76 6 A LEU 26 -105.17 59.27 6 A LYS 27 -173.64 64.94 7 A SER 17 -66.63 70.92 7 A ILE 18 -177.07 -39.19 7 A ILE 22 -128.02 -58.76 7 A ARG 31 172.80 110.00 8 A SER 11 -99.26 35.66 8 A ILE 13 -63.99 -79.32 8 A ARG 14 -38.76 -29.97 8 A TYR 15 -90.34 43.13 8 A ILE 18 -148.80 -47.10 8 A ALA 21 -101.66 -93.23 8 A ILE 22 66.76 -72.17 8 A LYS 27 56.64 79.12 8 A ARG 28 65.24 135.97 9 A SER 11 -93.64 44.60 9 A LEU 12 -141.25 -55.05 9 A SER 17 -69.42 60.27 9 A ILE 18 -160.42 -44.60 9 A ALA 21 -105.43 60.27 9 A ILE 22 -123.13 -54.56 9 A ARG 31 40.64 84.57 10 A SER 17 -69.65 60.54 10 A ILE 18 -142.36 -47.38 10 A ILE 22 -143.79 -67.00 10 A LYS 27 -121.86 -131.57 10 A ARG 28 -178.97 149.17 10 A THR 29 38.86 81.46 11 A ILE 18 -148.01 -47.20 11 A LYS 27 -164.54 88.57 11 A ARG 28 -179.36 114.60 12 A SER 11 -108.42 75.79 12 A LEU 12 -134.48 -59.36 12 A SER 17 -69.39 61.88 12 A ILE 18 -153.05 -46.42 12 A ILE 22 -145.34 -69.62 12 A ARG 31 66.97 138.13 13 A SER 11 -109.86 76.52 13 A LEU 12 -136.20 -53.71 13 A ILE 13 -61.08 -70.55 13 A SER 17 -69.48 60.43 13 A ILE 18 -160.37 -44.56 13 A ILE 22 -131.42 -66.88 13 A LYS 27 67.51 71.67 13 A ARG 31 179.94 146.84 14 A SER 3 -94.25 44.24 14 A ILE 4 -147.82 -59.64 14 A CYS 8 -152.16 -68.46 14 A SER 11 -94.42 32.56 14 A ILE 13 -58.39 -71.66 14 A ARG 14 -38.78 -29.98 14 A TYR 15 -90.76 44.76 14 A ILE 18 -149.79 -46.95 14 A ALA 21 -111.27 66.77 14 A ILE 22 -134.96 -50.62 14 A LYS 27 39.07 62.61 15 A SER 11 -90.39 44.25 15 A LEU 12 -102.54 -60.19 15 A ILE 18 -143.99 -47.42 15 A ALA 21 -102.83 70.23 15 A LYS 27 -124.01 -131.64 15 A ARG 28 61.12 113.64 15 A ARG 31 56.05 102.23 16 A ALA 21 -99.92 -94.18 16 A ILE 22 66.69 -72.07 16 A LYS 27 -120.86 -131.53 16 A ARG 28 62.28 86.11 17 A SER 2 -104.12 44.96 17 A SER 3 177.42 -35.70 17 A CYS 8 -151.04 -63.99 17 A SER 11 -90.36 41.36 17 A LEU 12 -144.18 -68.62 17 A ILE 13 -52.79 -72.76 17 A ARG 14 -38.71 -30.06 17 A TYR 15 -90.64 44.56 17 A ILE 18 -150.55 -46.86 17 A ALA 21 -106.19 64.10 17 A ARG 28 -45.93 152.44 17 A THR 29 -152.16 75.50 18 A ILE 4 -134.63 -64.30 18 A SER 11 -88.51 44.69 18 A LEU 12 -124.66 -58.89 18 A SER 17 -69.55 60.99 18 A ILE 18 -144.82 -47.30 18 A ARG 28 -177.95 80.42 18 A THR 29 -36.78 97.66 19 A SER 11 -100.62 40.29 19 A LEU 12 -141.30 -64.81 19 A SER 17 -68.39 65.73 19 A ILE 18 -157.39 -45.51 19 A LYS 27 -175.09 115.83 19 A ARG 28 -173.09 115.54 19 A ARG 31 -177.63 109.01 20 A SER 11 -109.01 76.34 20 A LEU 12 -169.94 -64.29 20 A SER 17 -69.36 61.88 20 A ILE 18 -145.68 -47.22 20 A ALA 21 -114.79 57.42 20 A ILE 22 -144.07 -59.95 20 A LYS 27 -122.46 -131.64 20 A ARG 28 59.42 154.27 20 A ARG 31 -161.12 97.61 BEST 20 NMR CONFORMERS OF D130I MUTANT T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA 2A ADRENERGIC RECEPTOR 1 N N A THR 1 A THR 1 HELX_P A TYR 15 A TYR 15 1 1 15 MEMBRANE PROTEIN HELIX-LINKER-HELIX, MEMBRANE PROTEIN ADA2A_HUMAN UNP 1 118 P08913 TSSIVHLCAISLDRYWSITQAIEYNLKRTPRR 118 149 1HO9 1 32 P08913 A 1 1 32 1 ASP conflict ILE 13 1HO9 A P08913 UNP 130 13